https://www.pharmaceutical-business-review.com/news/pfizer-to-take-over-icagen-210711/ 2011-07-21T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-canada-upgrades-ontario-plants-210711/ 2011-07-21T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-net-sales-up-in-q2-210711/ 2011-07-21T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/talon-recruits-first-patient-in-marqibo-phase-1-trial-210711/ 2011-07-21T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/avila-gets-new-us-patent-210711/ 2011-07-21T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-q2-revenue-climbs-210711/ 2011-07-21T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/athenahealth-to-take-over-proxsys-220711/ 2011-07-21T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-pharma-to-license-melanoma-vaccine-to-hussman-foundation-220711/ 2011-07-22T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biotech-uc-drug-gets-fda-committee-recommendation-220711/ 2011-07-22T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-allows-perrigo-to-market-cinnamon-coated-nicotine-gum-220711/ 2011-07-22T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/huya-zhongshan-national-health-technology-park-sign-pact-220711/ 2011-07-22T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-simcere-partner-to-form-jv-220711/ 2011-07-22T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/22nd-century-gets-fda-clearance-to-conduct-smoking-cessation-drug-trial-220711/ 2011-07-22T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-marketing-approval-for-orion-sedative-dexdor-220711/ 2011-07-22T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-boca-pain-drug-220711/ 2011-07-22T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/inotek-pharma-updates-on-glaucoma-drug-phase-2b-trial-220711/ 2011-07-22T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharma-starts-phase-1-type-2-diabetes-drug-trial-220711/ 2011-07-22T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-pharma-releases-metastatic-colorectal-cancer-drug-phase-ii-trial-220711/ 2011-07-22T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-introduces-revolade-votrient-220711/ 2011-07-22T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/adamis-pharma-prostate-cancer-drug-wins-us-patent-220711/ 2011-07-22T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/santhera-received-ema-acceptance-for-idebenone-maa-review-220711/ 2011-07-22T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-astar-etc-deploy-drug-screening-platform-at-singapore-screening-centre-220711/ 2011-07-22T09:12:00+00:00 https://www.pharmaceutical-business-review.com/news/hbys-invests-to-expand-otc-drug-business-in-china-260711/ 2011-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmalucence-sci-injection-receives-fda-approval-270711/ 2011-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biotech-gets-crl-for-simponi-sbla-250711/ 2011-07-24T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-sues-watson-on-generic-bph-drug-250711/ 2011-07-25T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-concludes-phase-i-pain-drug-trial-250711/ 2011-07-25T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-canada-receives-health-canada-approval-for-insomnia-drug-250711/ 2011-07-25T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-pancreatic-net-drug-gets-chmp-positive-opinion-250711/ 2011-07-25T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/pronova-teva-decide-to-terminate-us-litigation-case-250711/ 2011-07-25T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/repligen-starts-rg1068-drug-trial-250711/ 2011-07-25T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-to-take-over-amira-pharmaceuticals-250711/ 2011-07-25T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-nsclc-drug-receives-positive-chmp-opinion-250711/ 2011-07-25T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/cevec-pharma-receives-eur6m-for-protein-vaccine-business-250711/ 2011-07-25T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/polish-government-approves-helix-to-conduct-phase-iii-lung-cancer-drug-trial-250711/ 2011-07-25T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-advices-takeda-to-change-diabetes-drug-label-250711/ 2011-07-25T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-zydus-baddi-manufacturing-plant-250711/ 2011-07-25T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-introduces-generic-breast-cancer-drug-250711/ 2011-07-25T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-resolves-solodyn-patent-dispute-with-medicis-250711/ 2011-07-25T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/prasco-signs-supply-agreement-with-shionogi-250711/ 2011-07-25T09:39:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-gammagard-liquid-receives-fda-nod-250711/ 2011-07-25T09:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bionovo-completes-menerba-animal-toxicology-study-250711/ 2011-07-25T09:41:00+00:00 https://www.pharmaceutical-business-review.com/news/biodelivery-completes-pain-drug-phase-3-study-250711/ 2011-07-25T09:59:00+00:00 https://www.pharmaceutical-business-review.com/news/ipg-selects-genedata-selector-for-ipg-project-260711/ 2011-07-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-welchol-gets-fda-nod-260711/ 2011-07-25T23:27:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-selects-veeva-as-crm-solutions-provider-260711/ 2011-07-25T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/jhp-pharma-in-pact-to-produce-heart-failure-drug-260711/ 2011-07-26T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/avi-etepliren-releases-dmd-drug-phase-1b2-trial-results-260711/ 2011-07-26T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/onco-therapies-gemcitabine-for-injection-usp-gets-fda-approval-260711/ 2011-07-26T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/genesis-biopharma-signs-deal-with-lonza-260711/ 2011-07-26T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/laureate-signs-pact-to-produce-biosimilar-product-260711/ 2011-07-26T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/aeras-cnbg-to-co-develop-tb-vaccines-260711/ 2011-07-26T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/kemin-introduces-assuritea-green-260711/ 2011-07-26T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/adia-nutrition-introduces-probiotic-chews-260711/ 2011-07-26T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-commences-synovial-sarcoma-trial-260711/ 2011-07-26T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-conditional-approval-to-biogen-ms-drug-260711/ 2011-07-26T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-inks-rd-pact-with-medicis-260711/ 2011-07-26T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/vanda-pharma-gets-ema-acceptance-for-iloperidone-tablets-maa-260711/ 2011-07-26T09:38:00+00:00 https://www.pharmaceutical-business-review.com/news/intellitech-launches-i-fill-micro-liquid-dispensing-pump-270711/ 2011-07-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-enrolls-patients-for-ipx066-comparative-study-270711/ 2011-07-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/orasure-plans-acquisition-of-dna-genotek-270711/ 2011-07-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-q2-revenue-slightly-falls-270711/ 2011-07-26T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-to-construct-new-manufacturing-plant-in-hafia-270711/ 2011-07-27T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-gets-positive-data-from-enable-1-trial-270711/ 2011-07-27T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/cchit-grants-ambulatory-ehr-certification-for-raintree-version-10-software-270711/ 2011-07-27T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-q2-revenues-up-270711/ 2011-07-27T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-signs-licensing-deal-with-selexis-270711/ 2011-07-27T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-gets-glp-certificate-from-belgian-glp-270711/ 2011-07-27T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-inks-licensing-deal-with-merck-270711/ 2011-07-27T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-q2-net-revenue-climbs-270711/ 2011-07-27T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/nume-health-receives-funds-under-series-a-1-financing-round-270711/ 2011-07-27T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/4sc-hcc-drug-receives-ema-recommendation-270711/ 2011-07-27T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pbs-biotech-selects-gcms-to-market-single-use-bioreactors-in-korea-270711/ 2011-07-27T09:22:00+00:00 https://www.pharmaceutical-business-review.com/news/anavex-releases-preclinical-data-for-alzheimers-lead-compounds-270711/ 2011-07-27T09:56:00+00:00 https://www.pharmaceutical-business-review.com/news/inc-research-partners-with-debiopharm-270711/ 2011-07-27T09:58:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-zonegran-extended-license-application-gets-ema-acceptance-280711/ 2011-07-27T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-rolls-out-generic-cancer-drug-280711/ 2011-07-28T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaceutics-adds-hme-to-process-technology-portfolio-280711/ 2011-07-28T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-uses-genedata-expressionist-for-biomarker-discovery-280711/ 2011-07-28T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-q2-revenues-surge-280711/ 2011-07-28T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-inks-licensing-agreement-with-ironwood-280711/ 2011-07-28T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/novasep-gets-fda-nod-for-two-synthesis-sites-in-2011-280711/ 2011-07-28T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-dr-reddys-to-establish-jv-company-in-japan-280711/ 2011-07-28T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-isis-file-mipomersen-maa-with-ema-280711/ 2011-07-28T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/keryx-concludes-patient-recruitment-in-cancer-drug-phase-3-trial-280711/ 2011-07-28T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ribovax-licenses-sebvi-technology-to-pxt-280711/ 2011-07-28T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/teijin-pharma-introduces-febuxostat-in-korea-280711/ 2011-07-28T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/phytopharm-als-drug-obtains-orphan-drug-status-for-amyotrophic-lateral-sclerosis-drug-280711/ 2011-07-28T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/viamet-pharma-nih-to-co-develop-cryptococcal-meningitis-compound-280711/ 2011-07-28T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-nda-to-review-affymax-takeda-chronic-kidney-disease-drug-280711/ 2011-07-28T09:18:00+00:00 https://www.pharmaceutical-business-review.com/news/polaris-starts-dosing-in-hcc-drug-phase-3-trial-280711/ 2011-07-28T09:22:00+00:00 https://www.pharmaceutical-business-review.com/news/humabs-mrc-discover-new-flu-therapeutic-010811/ 2011-07-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacline-licenses-phillips-drug-delivery-technology-for-otc-drugs-020811/ 2011-07-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dkfz-adopts-roche-xcelligence-for-cell-proliferation-quantification-290711/ 2011-07-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-rolls-out-generic-contraceptive-pill-290711/ 2011-07-28T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-amylin-alkermes-submit-reply-for-bydureon-crl-290711/ 2011-07-29T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-concludes-phase-1-ibs-d-drug-trial-290711/ 2011-07-29T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/michigan-chooses-srs-ehr-technology-290711/ 2011-07-29T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/skyepharma-sanofi-in-pact-for-flutiform-290711/ 2011-07-29T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-to-start-rgn-259-phase-2-trial-290711/ 2011-07-29T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/newron-merck-conclude-patient-recruitment-in-settle-phase-iii-trial-290711/ 2011-07-29T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-janssen-postrate-cancer-drug-290711/ 2011-07-29T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-q2-net-sales-up-290711/ 2011-07-29T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/mcneil-plans-new-dosing-instructions-for-acetaminophen-products-290711/ 2011-07-29T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/yaupon-files-nda-for-mechlorethamine-with-fda-290711/ 2011-07-29T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/hemophilia-drug-trial-shows-hemostasis-controlled-bleeding-290711/ 2011-07-29T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-gets-fda-approval-for-anti-obesity-treatment-290711/ 2011-07-29T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fc-barcelona-gates-foundation-partner-for-polio-eradication-010811/ 2011-07-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/namn-signs-pact-with-dsv-020811/ 2011-07-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mogene-upgrades-extra-long-reads-on-roche-next-generation-sequencing-platform-010811/ 2011-07-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-orencia-sc-gets-fda-nod-for-ra-treatment-010811/ 2011-07-31T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-delays-pfizer-prevnar-13-approval-010811/ 2011-08-01T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/raqualia-cj-cheiljedang-sign-licensing-deal-010811/ 2011-08-01T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-q2-revenues-rise-010811/ 2011-08-01T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/medidata-ctms-to-support-qctr-clinical-operations-010811/ 2011-08-01T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/abd-serotecm-merck-amend-licensing-pact-010811/ 2011-08-01T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-generic-plavix-gets-fda-tentative-approval-010811/ 2011-08-01T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/dompe-sells-ovarian-cancer-treatment-to-aaa-010811/ 2011-08-01T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/algeta-selects-onet-to-manufacture-alpharadin-010811/ 2011-08-01T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/saga-to-take-over-allied-healthcare-010811/ 2011-08-01T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/synexus-gets-first-contract-for-mci-study-010811/ 2011-08-01T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmalucence-partners-bosch-packaging-for-filling-equipment-010811/ 2011-08-01T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/aenova-skyepharma-in-manufacturing-alliance-010811/ 2011-08-01T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/covidien-morphine-sulfate-oral-solution-gets-fda-nod-010811/ 2011-08-01T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-starts-patient-recruitment-in-kodiac-trial-020811/ 2011-08-02T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-concludes-liver-cancer-drug-phase-i-trial-020811/ 2011-08-02T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/advantagems-collaborates-with-stayinfront-020811/ 2011-08-02T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/kkr-acquires-pfizer-capsugel-business-020811/ 2011-08-02T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fera-pharma-rolls-out-four-ophthalmic-ointments-020811/ 2011-08-02T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-pharma-to-commence-livatag-production-020811/ 2011-08-02T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-seeks-ridaforolimus-marketing-approval-from-ema-080211/ 2011-08-02T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/swedish-orphan-biovitrum-recruits-first-patient-in-kiobrina-phase-iii-trial-020811/ 2011-08-02T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-awards-contracts-to-develop-drugs-for-acute-radiation-syndrome-020811/ 2011-08-02T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/nycomed-us-names-new-ceo-020811/ 2011-08-02T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-trade-name-for-astrazeneca-vandetanib-080211/ 2011-08-02T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-q2-revenues-fall-020811/ 2011-08-02T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-starts-patient-recruitment-in-psoriasis-drug-phase-23-trial-020811/ 2011-08-02T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/intelliject-e-cue-receives-fda-tentative-approval-020811/ 2011-08-02T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/catalyst-health-q2-revenue-surges-030811/ 2011-08-02T22:29:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-to-reissue-mylan-perforomist-patents-030811/ 2011-08-03T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-ranbaxy-to-widen-hybrid-business-model-in-mexico-030811/ 2011-08-03T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/t-system-to-integrate-ed-system-with-pepid-content-030811/ 2011-08-03T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-oral-contraceptive-gets-eu-approval-030811/ 2011-08-03T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pillar5-facility-gets-fda-nod-to-manufacture-intelgenx-antidepressant-030811/ 2011-08-03T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/nps-gsk-sign-new-calcilytics-agreement-030811/ 2011-08-03T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/cephalon-q2-net-sales-up-030811/ 2011-08-03T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/map-pharma-gets-fda-acceptance-to-file-levadex-nda-030811/ 2011-08-03T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/vectura-signs-agreement-for-copd-drug-030811/ 2011-08-03T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/oasmia-pharma-orion-terminate-paclical-pact-in-nordic-region-030811/ 2011-08-03T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/kadrige-inaugurates-new-office-in-us-030811/ 2011-08-03T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/nps-pharma-sees-rise-in-q2-revenues-q2-030811/ 2011-08-03T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-gets-fda-acceptance-to-file-ruxolitinib-nda-030811/ 2011-08-03T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/sunesis-pharma-leukemia-drug-gets-us-patent-080311/ 2011-08-03T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/charles-ross-launches-new-high-shear-mixer-system-030811/ 2011-08-03T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/bd-diagnostics-lab21-in-aspergillus-diagnostic-assay-development-agreement-040811/ 2011-08-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-q2-revenues-rise-040811/ 2011-08-03T19:31:00+00:00 https://www.pharmaceutical-business-review.com/news/hp-introduces-global-authentication-service-against-counterfeit-drugs-040811/ 2011-08-03T21:03:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serum-partner-to-develop-pneumococcal-conjugate-vaccine-040811/ 2011-08-03T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-gives-back-rapamycin-analogue-program-rights-to-biotica-040811/ 2011-08-04T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-united-therapeutics-deal-becomes-effective-040811/ 2011-08-04T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-treatment-for-scorpion-sting-040811/ 2011-08-04T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/surmodics-revenue-falls-in-q3-040811/ 2011-08-04T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-funds-avaxia-to-develop-anti-radiation-therapeutic-040811/ 2011-08-04T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/synco-dispatches-first-drug-batches-from-aseptic-filling-facility-040811/ 2011-08-04T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-signs-pact-with-safc-040811/ 2011-08-04T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/orion-nycomed-sign-deal-for-easyhaler-040811/ 2011-08-04T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-rhucin-phase-iii-trial-design-040811/ 2011-08-04T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-files-anda-for-type-2-diabetes-drug-040811/ 2011-08-04T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/lec-medical-to-unveil-new-range-of-pharmacy-refrigeration-040811/ 2011-08-04T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-life-science-extends-knockout-zfns-range-040811/ 2011-08-04T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/linxter-introduces-trackmyshots-smarphone-application-050811/ 2011-08-04T22:31:00+00:00 https://www.pharmaceutical-business-review.com/news/palatin-starts-obesity-drug-phase-1-trial-050811/ 2011-08-04T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-pradaxa-gets-ec-approval-050811/ 2011-08-05T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/amylin-takeda-to-terminate-pramlintidemetreleptin-development-050811/ 2011-08-05T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/micromet-q2-revenues-up-050811/ 2011-08-05T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-q2-revenues-nosedive-050811/ 2011-08-05T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-molmed-sign-deal-050811/ 2011-08-05T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/icig-to-take-over-roche-colorado-050811/ 2011-08-05T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/vwr-to-purchase-labpartner-050811/ 2011-08-05T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/irap-funds-delmar-pharma-for-gbm-drug-research-050811/ 2011-08-05T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-release-breast-cancer-drug-trial-results-050811/ 2011-08-05T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-presents-human-growth-hormone-phase-ii-positive-results-050811/ 2011-08-05T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharma-q2-revenues-climb-050811/ 2011-08-05T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-asthma-drug-phase-ii-trial-meets-primary-endpoint-050811/ 2011-08-05T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/imd-companies-purchases-botanical-sciences-050811/ 2011-08-05T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/dyax-treats-first-patient-in-phase-2-ecallantide-trial-050811/ 2011-08-05T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/dyadic-q2-revenues-up-050811/ 2011-08-05T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/firefly-receives-phase-ii-sbir-grant-for-microrna-profiling-in-cancer-diagnostics-080811/ 2011-08-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/blackstone-to-take-over-emdeon-080811/ 2011-08-07T20:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-hospira-oncology-drug-080811/ 2011-08-07T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-launches-new-diarrhea-treatments-in-india-080811/ 2011-08-08T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/gh-brands-changes-name-to-absorption-pharma-080811/ 2011-08-08T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-pharma-refiles-schizophrenia-drug-nda-with-fda-080811/ 2011-08-08T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-pharma-q2-net-loss-widens-080811/ 2011-08-08T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-botox-receives-positive-opinion-from-irish-health-authority-080811/ 2011-08-08T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-pharma-q2-revenue-up-080811/ 2011-08-08T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pg-q4-net-sales-rise-080811/ 2011-08-08T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/faulty-copy-rad51d-gene-causes-ovarian-cancer-icr-study-080811/ 2011-08-08T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/neuland-q1-revenues-up-080811/ 2011-08-08T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-q2-revenues-surge-080811/ 2011-08-08T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/adec-zuellig-pharma-in-pharma-kpo-joint-venture-080811/ 2011-08-08T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-reports-qnexa-phase-3-study-results-080811/ 2011-08-08T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-new-condom-gets-ce-mark-080811/ 2011-08-08T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-pharma-receives-european-patent-080811/ 2011-08-08T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-allows-teva-to-file-allergic-rhinitis-drug-nda-090811/ 2011-08-09T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-innopharma-generic-keppra-injection-anda-090811/ 2011-08-09T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/acurian-enters-into-agreement-with-pharma-firm-to-handle-patient-data-090811/ 2011-08-09T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-team-up-with-university-of-california-090811/ 2011-08-09T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/array-genentech-ink-oncology-pact-090811/ 2011-08-09T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/unigene-in-pact-with-gsk-090811/ 2011-08-09T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/unigene-q2-revenue-dips-090811/ 2011-08-09T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/idenix-pharma-q2-revenues-down-090811/ 2011-08-09T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/zydus-pharma-zynesher-acquire-nesher-from-k-v-pharma-090811/ 2011-08-09T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/hope-pharma-introduces-nithiodote-090811/ 2011-08-09T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/apceth-receives-manufacturer-licence-for-somatic-cell-therapeutics-090811/ 2011-08-09T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/siena-biotech-signs-mra-with-proteome-sciences-090811/ 2011-08-09T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cta-crpl-sign-services-agreement-080911/ 2011-08-09T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-pharma-q2-revenue-up-090811/ 2011-08-09T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/22nd-century-recruits-first-patients-in-smoking-cessation-aid-phase-ii-b-trial-090811/ 2011-08-09T08:24:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ipca-acquires-onyx-research-chemicals-090811/ 2011-08-09T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-unveils-sample-preservation-matrix-100811/ 2011-08-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-abbott-release-select-phase-2b-rrms-drug-trial-results-100811/ 2011-08-09T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-files-horizant-snda-with-fda-100811/ 2011-08-10T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-forest-file-nda-for-constipation-drug-100811/ 2011-08-10T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/government-of-nova-scotia-selects-deltaware-medigent-dis-100811/ 2011-08-10T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/sygnis-pharma-completes-patient-enrollment-in-ischemic-stroke-drug-trial-100811/ 2011-08-10T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-pharma-q2-revenues-climb-100811/ 2011-08-10T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-invest-795m-in-meta-metaldehyde-formulation-plant-100811/ 2011-08-10T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics-signs-crada-with-nci-100811/ 2011-08-10T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-for-adventrx-exelbine-nda-100811/ 2011-08-10T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/tga-to-commence-labelling-packaging-regulatory-review-100811/ 2011-08-10T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/agennix-gets-new-europen-patent-for-cancer-drug-100811/ 2011-08-10T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-q2-revenues-rise-100811/ 2011-08-10T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/intercept-servier-ink-deal-to-develop-diabetes-drug-100811/ 2011-08-10T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/access-pharma-adds-cspn-to-mugard-sales-network-100811/ 2011-08-10T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/precos-partners-rct-for-cancer-therapy-research-100811/ 2011-08-10T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/majority-uk-oncologists-prefer-doctorsnetuk/ 2011-08-10T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-tentative-approval-for-watson-generic-cholesterol-drug-110811/ 2011-08-11T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-starts-revamilast-phase-iib-trials-110811/ 2011-08-11T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/gns-healthcare-bms-sign-deal-110811/ 2011-08-11T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/genesis-biopharma-signs-crada-with-nci-110811/ 2011-08-11T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-gets-israeli-grant-110811/ 2011-08-11T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-chooses-veeva-system-crm-110811/ 2011-08-11T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-sees-rise-in-q2-revenues-110811/ 2011-08-11T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/acadia-pharma-q2-net-loss-widens-110811/ 2011-08-11T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/aeras-oetc-commence-tb-drug-phase-iib-trial-110811/ 2011-08-11T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-gets-fda-approval-for-hiv-drug-110811/ 2011-08-11T04:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/nutra-pharma-to-market-otc-nyloxin-in-india-110811/ 2011-08-11T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-acknowledges-bydureon-resubmission-110811/ 2011-08-11T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-develops-first-candidate-under-lilly-pact-120811/ 2011-08-11T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/teijin-pharma-astellas-pharma-sign-pact-for-gout-drug-110811/ 2011-08-11T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-submits-additional-indication-application-for-penicillin-formultions-110811/ 2011-08-11T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/mmodal-signs-new-agreement-with-transcend-120811/ 2011-08-11T20:17:00+00:00 https://www.pharmaceutical-business-review.com/news/destinationrx-introduces-mobile-drugcompare-tool-120811/ 2011-08-11T23:01:00+00:00 https://www.pharmaceutical-business-review.com/news/mexico-issues-gmp-certificate-to-sinovac-120811/ 2011-08-11T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/marken-names-interim-president-for-clinical-trials-distribution-business/ 2011-08-12T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-ships-morphine-sulfate-oral-solution-120811/ 2011-08-12T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/afc-concludes-contract-manufacturing-deal-with-chimerix-120811/ 2011-08-12T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-map-pharma-migraine-drug-120811/ 2011-08-12T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/transcept-pharma-q2-net-loss-widens-120811/ 2011-08-12T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/american-pacific-q2-revenues-surge-120811/ 2011-08-12T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/anda-to-establish-distribution-facility-in-olive-branch-120811/ 2011-08-12T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-guides-advaxis-over-adxs-psa-clinical-trials-120811/ 2011-08-12T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/mannkind-finalizes-design-for-insulin-therapy-trials-120811/ 2011-08-12T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-q2-sales-drop/ 2011-08-12T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/avanirpharma-files-lawsuits-against-par-actavis-120811/ 2011-08-12T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-pharma-rolls-out-generic-benign-prostatic-hyperplasia-drug-120811/ 2011-08-12T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/transgenomic-q2-net-sales-climb-120811/ 2011-08-12T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharma-chdi-renew-hd-drug-pact-120811/ 2011-08-12T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/allon-updates-on-neuroprotective-drug-phase-23-trial-150811/ 2011-08-14T22:18:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-introduces-volini-duo-pain-killer-in-india-150811/ 2011-08-14T22:28:00+00:00 https://www.pharmaceutical-business-review.com/news/trimeris-sees-rise-in-q2-revenue-150811/ 2011-08-14T22:48:00+00:00 https://www.pharmaceutical-business-review.com/news/thorne-research-gets-qcell-marketing-rights-from-helsinn-150811/ 2011-08-14T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-q2-net-loss-widens-150811/ 2011-08-15T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nordion-to-implement-pilgrim-on-demand-150811/ 2011-08-15T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/epicept-updates-on-amiket-development-program-150811/ 2011-08-15T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/new-studies-offer-evidence-based-dosing-guidance-for-colchicine-150811/ 2011-08-15T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-calls-back-simvastatin-fresh-lots-from-us-150811/ 2011-08-15T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/addex-pharma-names-new-ceo-150811/ 2011-08-15T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-licenses-vemurafenib-to-chugai-150811/ 2011-08-15T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-to-widen-sobi-deal-for-ruconest-150811/ 2011-08-15T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-biotech-q2-sales-surge-150811/ 2011-08-15T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/mjff-partners-shake-it-up-foundation-australia-150811/ 2011-08-15T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/starpharma-starts-phase-2-vivagel-trial-150811/ 2011-08-15T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/niaid-funds-kineta-for-next-generation-antiviral-program-150811/ 2011-08-15T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-healthcare-breaches-clause-2-abpi-code-of-practice-170811/ 2011-08-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-rotem-hemostasis-delta-analyzer-160811/ 2011-08-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/court-rules-in-favor-of-pfizer-over-viagra-patent-160811/ 2011-08-16T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ultragenyx-pharma-doses-first-patient-in-hibm-drug-phase-1-trial-160811/ 2011-08-16T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/china-shenghuo-q2-sales-climb-58-160811/ 2011-08-16T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-pharma-gsk-release-ascend-pd-phase-iii-trial-results-160811/ 2011-08-16T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-rolls-out-head-lice-treatment-160811/ 2011-08-16T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/west-pharma-widens-rd-center-160811/ 2011-08-16T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/intercell-sees-rise-in-q2-revenues-160811/ 2011-08-16T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/niaid-to-start-phase-1-trial-with-destiny-pharma-drug-160811/ 2011-08-16T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/biosceptre-gets-au8m-to-develop-nmsc-drug-160811/ 2011-08-16T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/bac-in-pact-with-bms-160811/ 2011-08-16T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/aegis-peptide-analogs-receive-us-patent-160811/ 2011-08-16T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/novel-flavonoid-compounds-reduce-cancer-cell-growth-heartlink-160811/ 2011-08-16T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/lotus-pharma-q2-revenues-up-160811/ 2011-08-16T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/inviragen-gets-nih-funding-to-develop-chikv-vaccine-160811/ 2011-08-16T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/mjff-awards-research-grant-to-melior-160811/ 2011-08-16T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/avi-biopharma-starts-patient-dosing-in-dmg-drug-phase-2-trial-160811/ 2011-08-16T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/visiongain-predicts-boom-in-pharma-contract-manufacturing-market-190811/ 2011-08-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sobran-pre-clinical-research-facility-receives-aaalac-iso-certification-230811/ 2011-08-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-two-new-strengths-of-cpp-drug-gets-fda-nod-170811/ 2011-08-16T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-sets-up-new-subsidiary-in-mexico-170811/ 2011-08-17T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-to-establish-nutrition-manufacturing-plant-in-china-170811/ 2011-08-17T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/axolotl-emr-lite-wins-onc-atcb-ambulatory-ehr-certification-170811/ 2011-08-17T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/sg-austria-gets-milestone-payment-170811/ 2011-08-17T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-marshall-edward-me-143-170811/ 2011-08-17T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/gulf-resources-q2-net-revenue-up-170811/ 2011-08-17T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/china-ruitai-sees-rise-in-q2-sales-170811/ 2011-08-17T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/4-antibody-partners-hgs-for-antibody-drug-candidates-170811/ 2011-08-17T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-delays-regeneron-eylea-bla-review-170811/ 2011-08-17T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/encap-drug-delivery-launches-colon-screen-170811/ 2011-08-17T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-to-take-over-paa-labs-170811/ 2011-08-17T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-receives-health-canada-acceptance-for-egrifta-nds-170811/ 2011-08-17T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-treats-first-patient-in-head-neck-cancer-drug-trial-170811/ 2011-08-17T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-pharma-selects-vifor-to-market-ferinject-in-mena-region/ 2011-08-17T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/coti-reports-anti-cancer-drug-study-results-180811/ 2011-08-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/verona-pharma-concludes-asthma-drug-phase-ii-trial-180811/ 2011-08-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cortex-pharma-q2-net-loss-shrinks-180811/ 2011-08-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-pharma-sues-mylan-on-migraine-drug-180811/ 2011-08-17T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/australia-selects-accenture-to-build-pcehr-system-180811/ 2011-08-18T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-to-review-pfizer-cancer-drugs-180811/ 2011-08-18T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-protalix-taliglucerase-alfa-resubmitted-nda-180811/ 2011-08-18T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/majenta-to-develop-multi-site-data-storage-solution-for-bio-rad-180811/ 2011-08-18T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-starts-lymphoma-drug-phase-1b2-study-180811/ 2011-08-18T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-pharma-to-suspend-axomadol-development-pact-180811/ 2011-08-18T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/argenta-widens-drug-discovery-deal-with-genentech-180811/ 2011-08-18T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/skyepharma-licenses-lyon-manufacturing-plant-to-aenova-180811/ 2011-08-18T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-phase-3-zohydro-study-meets-primary-endpoint-180811/ 2011-08-18T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/scancell-updates-on-cancer-vaccine-phase-i-clinical-trial-180811/ 2011-08-18T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-completes-sugardown-trial-180811/ 2011-08-18T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/allos-recruits-first-patient-in-phase-3-ptcl-drug-trial-180811/ 2011-08-18T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gsn-unveils-non-invasive-prenatal-test-190811/ 2011-08-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/extedo-launches-eursvalidator-advanced-version-190811/ 2011-08-18T19:56:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-accepts-to-review-merck-ariad-ridaforolimus-nda-190811/ 2011-08-18T22:09:00+00:00 https://www.pharmaceutical-business-review.com/news/alto-pharma-to-introduce-dermsafe-hand-sanitizer-190811/ 2011-08-18T22:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-fda-jointly-inspect-pii-190811/ 2011-08-18T22:17:00+00:00 https://www.pharmaceutical-business-review.com/news/urmc-temple-university-school-of-pharmacy-in-pact-to-develop-new-drugs-190811/ 2011-08-18T22:19:00+00:00 https://www.pharmaceutical-business-review.com/news/trevena-gets-nih-grant-190811/ 2011-08-18T22:47:00+00:00 https://www.pharmaceutical-business-review.com/news/nps-pharma-files-gattex-nda-with-fda-190811/ 2011-08-18T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-to-dara-cancer-drug-180911/ 2011-08-19T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-allows-colucid-to-initiate-migraine-drug-trials/ 2011-08-19T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharma-rolls-out-vecuronium-bromide-for-injection-190811/ 2011-08-19T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/intellipharmaceutics-par-pharmaceutical-expand-adhd-drug-deal-190811/ 2011-08-19T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/antigen-express-updates-on-breast-cancer-drug-trial-190811/ 2011-08-19T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/furiex-pharma-gets-loan-for-clinical-stage-compounds-development-190811/ 2011-08-19T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-blueprint-funds-to-discover-neurological-disorders-drugs-190811/ 2011-08-19T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/atrium-takes-over-enzimas-220811/ 2011-08-19T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-cancer-drug-gets-fda-nod-220811/ 2011-08-21T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharma-acquires-ab-sanitas-220811/ 2011-08-22T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-nexmed-otc-anti-fungal-drug-220811/ 2011-08-22T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-sues-novo-nordisk-on-generic-diabetes-drug-220811/ 2011-08-22T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-releases-results-from-phase-iii-ocriplasmin-program-220811/ 2011-08-22T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-pharma-recruits-first-patient-in-lucentis-study-220811/ 2011-08-22T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/norgine-licenses-moviprep-to-nycomed-220811/ 2011-08-22T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/nedo-to-fund-activus-pharma-for-opthalmic-solutions-development-220811/ 2011-08-22T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-gets-license-to-glumetza-from-depomed-220811/ 2011-08-22T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-acquires-minority-stake-in-autifony-220811/ 2011-08-22T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/frutarom-takes-over-aromco-220811/ 2011-08-22T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/bdsi-to-roll-out-onsolis-in-canada-220811/ 2011-08-22T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/cytokinetics-reports-phase-i-iia-results-of-cardiac-myosin-activator-220811/ 2011-08-22T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/shangpharma-q2-revenues-climb-26-220811/ 2011-08-22T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/us-court-rules-in-favour-of-affymetrix-220811/ 2011-08-22T09:01:00+00:00 https://www.pharmaceutical-business-review.com/news/cvs-caremark-names-new-president-230811/ 2011-08-22T12:15:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-pharma-chronic-hepatitis-c-drug-gets-health-canada-nod-230811/ 2011-08-22T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-rolls-out-brilinta-tablets-in-us-230811/ 2011-08-23T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/novadel-pharma-signs-pact-with-rechon-230811/ 2011-08-23T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/girard-gibbs-sues-takeda-eli-lilly-on-actos-230811/ 2011-08-23T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-introduces-centricity-business-50-220811/ 2011-08-23T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/pra-inaugurates-new-office-in-romania-230811/ 2011-08-23T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/symphogen-starts-phase-2-trial-in-scchn-patients-230811/ 2011-08-23T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/ohr-pharma-receives-us-patent-for-composition-of-squalamine-230811/ 2011-08-23T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/prasco-to-market-generic-furadantin-oral-suspension-230811/ 2011-08-23T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/skystar-q2-revenue-up-230811/ 2011-08-23T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/healthnostics-to-introduce-microfill-21600-230811/ 2011-08-23T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/isconova-genocea-widen-licensing-deal-230811/ 2011-08-23T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-fast-track-status-to-algeta-radium-223-chloride-230811/ 2011-08-23T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-pharma-to-take-over-clinical-trial-supplies-business-of-aptuit-230811/ 2011-08-23T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-recruits-first-patient-in-lung-cancer-drug-phase-iii-clinical-program-230811/ 2011-08-23T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/reflect-to-develop-new-inventory-control-automation-240811/ 2011-08-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fuji-xerox-selects-extedo-ectdmanager-suite-240811/ 2011-08-23T18:46:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-starts-phase-ii-adcetris-trial-240811/ 2011-08-23T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/onset-introduces-hylatopicplus-cream-240811/ 2011-08-24T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/fimea-issues-eu-gmp-certificate-for-simcere-biqi-240811/ 2011-08-24T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-names-new-president-for-animal-health-unit-240811/ 2011-08-24T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/idc-gp-pharm-gets-license-for-multikine-in-argentina-venezuela-240311/ 2011-08-24T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-apricus-otc-anti-itch-drug-240811/ 2011-08-24T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/ashland-acquires-isp-for-32bn-240811/ 2011-08-24T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/mhra-approves-ajanta-pharma-paithan-manufacturing-plant-240811/ 2011-08-24T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/aventis-pharma-to-take-over-universal-medicare-indian-nutraceutical-business-240811/ 2011-08-24T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/united-freedom-c2-phase-3-trial-fails-to-meet-primary-endpoint-240811/ 2011-08-24T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-to-pharmasset-hcv-drug-240811/ 2011-08-24T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-completes-first-patient-dosing-in-pd-drug-trial-240811/ 2011-08-24T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/unilife-develops-safety-syringe-to-reconstitute-lyophilized-drugs-240811/ 2011-08-24T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/therabiogen-ships-theramax-allergy-relief-to-food-lion-supermarkets-240811/ 2011-08-24T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharma-to-take-over-anchen-240811/ 2011-08-24T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/kibow-renews-licensing-marketing-agreement-300811/ 2011-08-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eclinical-consulting-connects-to-datatrak-connect-partner-program-250811/ 2011-08-24T20:26:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-healthcare-inks-loi-to-take-over-premier-technology-250811/ 2011-08-24T20:46:00+00:00 https://www.pharmaceutical-business-review.com/news/dey-pharma-to-provide-epipen-auto-injectors-250811/ 2011-08-25T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-completes-patient-recruitment-in-phase-2-dry-eye-drug-trial-250811/ 2011-08-25T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-botox-gets-fda-nod-250811/ 2011-08-25T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/d-pharm-gets-kfda-approval-for-phase-iii-macsi-study-in-korea-250811/ 2011-08-25T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-pharma-q1-revenue-rises-250811/ 2011-08-25T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-pharma-updates-on-phase-ii-breast-cancer-trial-250811/ 2011-08-25T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/nanobio-releases-results-from-rcv-vaccine-studies-250811/ 2011-08-25T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/lightlake-to-initiate-phase-ii-trial-for-treating-binge-eating-disorder-250811/ 2011-08-25T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/rxgen-miragen-receive-nih-grant-250811/ 2011-08-25T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/kvk-tech-signs-licensing-deal-with-hi-tech-pharmacal-250811/ 2011-08-25T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bionor-pharma-to-initiate-hiv-vacc-4x-combination-trial-250811/ 2011-08-25T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/senesco-to-evaluate-multiple-myeloma-drug-with-mayo-250811/ 2011-08-25T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/simcere-anti-rheumatic-drug-wins-sfda-approval-250811/ 2011-08-25T09:06:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-international-buys-baxa-250811/ 2011-08-25T09:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-allows-shire-to-market-hae-drug-260811/ 2011-08-26T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-adds-new-vitamin-d-supplement-to-medpodium-portfolio-260811/ 2011-08-26T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-boehringer-eli-lilly-type-2-diabetes-drug-260811/ 2011-08-26T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/impactrx-names-new-ceo-260811/ 2011-08-26T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/masters-pharma-obtains-dea-registration-260811/ 2011-08-26T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/usana-to-expand-operations-into-france-belgium-260811/ 2011-08-26T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/innovation-rxsafe-join-to-distribute-pharmacy-automation-solutions-260811/ 2011-08-26T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/qrxpharma-files-moxduo-ir-nda-with-fda-260811/ 2011-08-26T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ah-signs-pact-with-norgine-260811/ 2011-08-26T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/china-nuokang-q2-net-revenue-falls-260811/ 2011-08-26T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-partners-xcelience-to-accelerate-drug-intermediates-to-clinical-trials-260811/ 2011-08-26T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/promega-establishes-new-cgmp-plant-260811/ 2011-08-26T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bluefish-purchases-bmm-pharma-260811/ 2011-08-26T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-set-up-new-corporate-centre-in-denmark-260811/ 2011-08-26T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-names-new-president-of-millipore-division-260811/ 2011-08-26T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-releases-results-from-phase-1a-anthrax-vaccine-trial-260811/ 2011-08-26T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/halo-bio-licenses-mv-rna-to-tekmira-260811/ 2011-08-26T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-to-provide-reaxys-access-to-pharmaron-290811/ 2011-08-29T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/xendo-batavia-in-biopharma-process-collaboration-290811/ 2011-08-29T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-dendreon-cancer-drug-manufacturing-facility-in-atlanta-290811/ 2011-08-29T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-nod-to-pfizer-lung-cancer-drug-xalkori-290811/ 2011-08-29T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/gentiva-health-to-sell-remaining-stake-in-carecentrix-290811/ 2011-08-29T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-submits-oab-drug-application-to-fda-ema-290811/ 2011-08-29T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-grants-sobi-additional-territories-to-market-hae-drug-290811/ 2011-08-29T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-eisai-to-debut-pei-dug-lipacreon-in-japan-290811/ 2011-08-29T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/isconova-releases-matrix-m-human-panfluvac-trial-data-290811/ 2011-08-29T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/actelion-reports-ipf-drug-study-results-290811/ 2011-08-29T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novalix-galapagos-in-osteoarthritis-discovery-research-collaboration-290811/ 2011-08-29T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-requests-novartis-gouty-arthritis-drug-additional-clinical-data-290811/ 2011-08-29T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/zymeworks-merck-partner-to-develop-bi-specific-antibody-therapeutics-290811/ 2011-08-29T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-postpones-review-of-progensa-pca3-assay-300811/ 2011-08-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jennewein-in-licensing-deal-with-pfizer-nutrition-300811/ 2011-08-30T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/adimab-signs-agreements-with-biogen-idec-novo-nordisk-300811/ 2011-08-30T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/amorfix-licenses-promis-technology-to-prevent-300811/ 2011-08-30T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/curemark-releases-results-from-cm-182-study-300811/ 2011-08-30T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmavigilant-introduces-i-monitor-300811/ 2011-08-30T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-to-aicuris-letermovir-300811/ 2011-08-30T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-inspiration-to-establish-european-hemophilia-commercial-organization-300811/ 2011-08-30T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/dmv-fonterra-to-acquire-brahmar-cellulose-300811/ 2011-08-30T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/esc-recommends-astrazeneca-brilique-as-treatment-for-acs-300811/ 2011-08-30T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-chooses-icon-for-early-phase-clinical-development-services-300811/ 2011-08-30T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-starts-patient-dosing-in-advanced-melanoma-drug-phase-1-trial-300811/ 2011-08-30T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-for-nupathe-zelrix-nda-300811/ 2011-08-30T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-millipore-takes-over-amnis-300811/ 2011-08-30T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/avantra-renames-to-courtagen-300811/ 2011-08-30T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-perrigo-ketoconazole-foam-2-300811/ 2011-08-30T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/talon-signs-spa-with-fda-for-marqibo-phase-3-trial-300811/ 2011-08-30T08:52:00+00:00 https://www.pharmaceutical-business-review.com/news/reflect-scientific-introduces-cold-chain-management-guidance-050911/ 2011-08-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/huber-expands-quincy-facility-050911/ 2011-08-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-rolls-out-generic-allegra-extended-release-tablets-310811/ 2011-08-31T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pharma-firm-to-continue-pact-with-cegedim-relationship-management-310811/ 2011-08-31T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/inventiv-q2-net-revenue-rises-310811/ 2011-08-31T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/toyama-eisai-file-maa-for-anti-rheumatic-drug-310811/ 2011-08-31T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/adamis-pharma-recruits-first-patient-in-prostate-cancer-drug-trial-310811/ 2011-08-31T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharma-to-take-over-afexa-310811/ 2011-08-31T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bionovo-releases-positive-results-from-menerba-trial-310811/ 2011-08-31T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/progenics-salix-relistor-snda-filing-gets-fda-acceptance-310811/ 2011-08-31T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/insight-pharma-takes-over-monistat-business-in-north-america-310811/ 2011-08-31T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/sinclair-is-pharma-licenses-episil-to-teva-310811/ 2011-08-31T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/star-scientific-introduces-anatabloc-dietary-supplement-310811/ 2011-08-31T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sirona-biochem-formulates-cancer-vaccine-antigen-310811/ 2011-08-31T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-reports-seizure-drug-study-results-310811/ 2011-08-31T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-concludes-patient-recruitment-in-three-phase-3-trials-310811/ 2011-08-31T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/urac-gives-health-utilization-management-accreditation-to-magellan-010911/ 2011-08-31T19:51:00+00:00 https://www.pharmaceutical-business-review.com/news/hatchtech-concludes-treatment-in-head-lice-drug-phase-2b-trial-010911/ 2011-09-01T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-resolves-patent-dispute-with-pfizer-over-lipitor-tablets-010911/ 2011-09-01T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/greenway-launches-remote-clinic-primemobile-010911/ 2011-09-01T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lupin-tramadol-hcl-er-tablets-anda-010911/ 2011-09-01T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-starts-dosing-in-phase-12a-cancer-drug-trial-010911/ 2011-09-01T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/mannatech-adds-vitamin-d-to-omega-3-supplement-010911/ 2011-09-01T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-pharma-mmv-widen-malaria-pact-010911/ 2011-09-01T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-q2-total-revenues-down-010911/ 2011-09-01T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/kuros-concludes-patient-enrollment-in-diabetic-foot-ulcers-drug-phase-iib-trial-010911/ 2011-09-01T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-tarceva-gets-ec-nod-010911/ 2011-09-01T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-approval-for-sagent-orphenadrine-citrate-injection-usp-010911/ 2011-09-01T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-submits-tesamorelin-maa-in-brazil-010911/ 2011-09-01T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/selecta-signs-subcontract-with-saic-010911/ 2011-09-01T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pevion-csl-in-therapeutic-candida-vaccine-agreement-010911/ 2011-09-01T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-sues-impax-on-nuedexta-010911/ 2011-09-01T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/verinata-wins-us-patent-for-fetal-aneuploidy-determination-method-020911/ 2011-09-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/max-neeman-unveils-customized-software-for-clinical-studies-in-india-020911/ 2011-09-01T21:30:00+00:00 https://www.pharmaceutical-business-review.com/news/synageva-in-rd-pact-with-mitsubishi-tanabe-020911/ 2011-09-02T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-gets-fda-acceptance-to-review-ed-drug-nda-020911/ 2011-09-02T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-to-suspend-parietaciphex-capsules-50mg-development-020911/ 2011-09-02T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mednet-solutions-introduces-imednet-edc-020911/ 2011-09-02T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-deploys-2000l-sub-at-copenhagen-manufacturing-plant-020911/ 2011-09-02T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-nucleic-acid-peptide-drug-delivery-platform-gets-noa-from-uspto-020911/ 2011-09-02T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-releases-top-line-results-from-phase-iiib-saturn-trial-020911/ 2011-09-02T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/china-botanic-klp-set-up-research-laboratory-in-china-020911/ 2011-09-02T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/anaptysbio-completes-therapeutic-antibody-generation-project-020911/ 2011-09-02T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-relocate-research-units-to-cambridge-facility-020911/ 2011-09-02T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/chugai-pharma-in-license-agreement-with-roche-020911/ 2011-09-02T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/chesapeake-to-take-over-cortegra-020911/ 2011-09-02T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-commences-type-ii-dyslipidemia-drug-phase-ii-trial-020911/ 2011-09-02T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fero-names-new-president-020911/ 2011-09-02T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/reneuron-updates-on-ren001-pisces-phase-i-trial/ 2011-09-02T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/biovigilant-submits-rapid-biologic-detection-systems-dmfs-with-fda-020911/ 2011-09-02T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/amerisourcebergen-purchases-premier-source-020911/ 2011-09-02T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/multicare-to-market-sanofi-aventis-solian-stilnox-in-philippines-020911/ 2011-09-02T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/zeon-imcd-in-pact-to-distribute-cpme-in-european-market-020911/ 2011-09-02T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-agrees-to-return-pam-program-rights-to-addex-050911/ 2011-09-04T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-to-make-changes-in-hepatitis-c-drug-trial-design-050911/ 2011-09-05T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/systech-signs-agreement-with-zetes-050911/ 2011-09-05T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/berlin-pharma-to-market-acino-products-in-thailand-050911/ 2011-09-05T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/usp-opens-new-testing-facility-in-india-050911/ 2011-09-05T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/mesoblast-gets-ema-nod-to-start-revascor-phase-2-trial-050911/ 2011-09-05T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/skyepharma-provides-update-on-diabetes-drug-development-050911/ 2011-09-05T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-pancreatic-net-drug-gets-ec-nod-050911/ 2011-09-05T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ptc-genzyme-amend-ataluren-deal-050911/ 2011-09-05T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-evec-team-up-for-fully-human-antibody-050911/ 2011-09-05T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/who-fip-take-initiative-to-fight-against-tb-050911/ 2011-09-05T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-introduces-esomeprazole-tablets-in-uk-050911/ 2011-09-05T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/anlit-frutarom-develop-probiotics-supplement-for-immune-health-050911/ 2011-09-05T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/suven-nces-receive-patents-in-australia-new-zealand-050911/ 2011-09-05T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cellcura-partners-idt-biologika-for-protein-free-media-070911/ 2011-09-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/qiagen-eli-lilly-in-companion-diagnostic-development-deal-060911/ 2011-09-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-roche-in-pact-for-ad-drug-060911/ 2011-09-06T00:35:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-to-roll-out-two-otc-drugs-060911/ 2011-09-06T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/amt-nih-widen-aav5-licensing-deal-060911/ 2011-09-06T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/amerisourcebergen-acquired-intrinsiq-060911/ 2011-09-06T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/4sc-phase-ii-saphire-hl-drug-trial-shows-anti-tumour-activity-060911/ 2011-09-06T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/noxxon-begins-phase-i-trial-on-compound-to-treat-anemia-of-chronic-disease-060911/ 2011-09-06T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/amakem-receives-eur18m-for-ophthalmology-drug-development-060911/ 2011-09-06T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/hybrigenics-gets-french-approval-for-phase-ii-psoriasis-drug-trial-060911/ 2011-09-06T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/veloxis-phase-3-lcp-tacro-trial-shows-efficacy-060911/ 2011-09-06T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/sawai-to-develop-distribute-acino-oncology-product-in-japan-060911/ 2011-09-06T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-introduces-therapeutic-heparin-in-us-060911/ 2011-09-06T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-pharma-quintiles-ics-in-pact-to-commercialize-exparel-090611/ 2011-09-06T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/durect-concludes-patient-dosing-in-besst-phase-iii-posidur-trial-060911/ 2011-09-06T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-receives-us-patent-to-treat-sexual-dysfunction-060911/ 2011-09-06T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/oxis-appoints-david-saloff-as-ceo-060911/ 2011-09-06T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-armada-sign-pact-for-alferon-n-injection-060911/ 2011-09-06T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/cormedix-makes-changes-in-crmd001-deal-with-shiva-070911/ 2011-09-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-pharma-gsk-widen-rd-pact-090711/ 2011-09-07T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ab-science-enrolls-first-patient-in-masitinib-phase-3-trial-090711/ 2011-09-07T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-receive-945m-from-barda-for-antibiotic-research-070911/ 2011-09-07T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-europe-chooses-veeva-systems-crm-suite-070911/ 2011-09-07T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-to-acquire-biogen-dompe-joint-ventures-in-italy-switzerland-070911/ 2011-09-07T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-haloperidol-injection-usp-gets-fda-nod-070911/ 2011-09-07T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-starts-second-phase-i-bal30072-trial-070911/ 2011-09-07T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/viropharma-buccolam-gets-puma-from-ec-070911/ 2011-09-07T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-ascenta-sign-licensing-deal-to-develop-at-406-070911/ 2011-09-07T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-starts-phase-2-copd-drug-trial-070911/ 2011-09-07T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-cilag-prostate-cancer-drug-gets-ec-approval-070911/ 2011-09-07T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-biotech-concludes-enrollment-in-phase-iib-type-ii-diabetes-drug-trial-070911/ 2011-09-07T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-commences-two-phase-ii-breast-cancer-drug-trials-070911/ 2011-09-07T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/harmonix-introduces-non-prescription-sleep-aid-070911/ 2011-09-07T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/malvern-purdue-collaborate-to-advance-nanotechnology-130911/ 2011-09-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-q1-net-sales-surge-140911/ 2011-09-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mpr-introduces-drug-interactions-checker-on-apple-ios-android-platforms-080911/ 2011-09-07T20:38:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-rolls-out-levetiracetam-tablets-080911/ 2011-09-08T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharma-alcobra-phase-ii-adhd-drug-trial-meets-efficacy-080911/ 2011-09-08T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/xcelience-to-enhance-manufacturing-packaging-capabilities-080911/ 2011-09-08T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ipierian-designates-nancy-stagliano-as-ceo-080911/ 2011-09-08T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-gets-sbir-grant-080911/ 2011-09-08T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-ojsc-diod-form-jv-in-russia-080911/ 2011-09-08T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/lanxess-to-enhance-thionyl-chloride-production-in-nagda-site-india-080911/ 2011-09-08T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/bhr-pharma-achieves-recruitment-milestone-in-synapse-phase-3-trial-080911/ 2011-09-08T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-sirolimus-gets-ec-orphan-drug-status-080911/ 2011-09-08T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/avita-medical-mena-united-sign-jv-for-recell-spray-on-skin-080911/ 2011-09-08T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-chooses-biologics-to-introduce-zelboraf-080911/ 2011-09-08T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/beacon-pharma-licenses-six-products-to-alliance-080911/ 2011-09-08T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/xenetic-receives-noa-for-co-delivery-technology-080911/ 2011-09-08T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-reports-placental-expanded-cells-preclinical-trial-results-080911/ 2011-09-08T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/cornerstone-names-kenneth-mcbean-as-new-president-080911/ 2011-09-08T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-jubilant-generic-protonix-drug-080911/ 2011-09-08T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-introduces-new-line-of-dietary-supplements-140911/ 2011-09-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/labcorp-extends-partnership-with-unitedhealthcare-090911/ 2011-09-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-allows-laureate-rsg-to-submit-ectd-090911/ 2011-09-08T21:11:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-takes-over-amira-090911/ 2011-09-09T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-pharma-concludes-recruitment-in-bavituximab-phase-ii-trial-090911/ 2011-09-09T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/jjprd-af-drug-gets-fda-advisory-committee-recommendation-090911/ 2011-09-09T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/atheronova-in-licensing-deal-with-maxwell-090911/ 2011-09-09T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-animal-health-jilin-guoyuan-signs-pact-090911/ 2011-09-09T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/campbell-alliance-names-new-ceo-090911/ 2011-09-09T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/marshall-edwards-starts-me-143-phase-i-trial-090911/ 2011-09-09T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/nektar-starts-dosing-in-second-phase-i-nktr-181-trial-090911/ 2011-09-09T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-pharma-licenses-zertane-south-korean-marketing-rights-to-daewoong-090911/ 2011-09-09T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/huya-zhejiang-in-pact-to-ramp-up-tcm-development-090911/ 2011-09-09T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/protalix-reports-anti-gaucher-drug-phase-iii-trial-results-090911/ 2011-09-09T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/elusys-gets-689m-funding-from-us-government-090911/ 2011-09-09T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/numab-collaborates-with-sucampo-090911/ 2011-09-09T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-everolimus-tablets-wins-ec-approval-090911/ 2011-09-09T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/epharmasolutions-installs-global-2-way-sms-latest-version-for-clinical-trials-120911/ 2011-09-11T18:51:00+00:00 https://www.pharmaceutical-business-review.com/news/wellpoint-ibm-partner-to-develop-watson-based-solutions-120911/ 2011-09-11T19:41:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/roche-initiates-down-syndrome-drug-phase-1-trial-120911/ 2011-09-11T23:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pharmathene-completes-final-commercial-scale-up-activities-for-sparvax-120911/ 2011-09-11T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/juvaris-colby-pharma-in-jvrs-100-cldc-technology-licensing-agreement-120911/ 2011-09-11T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/trophos-concludes-patient-enrolment-in-spinal-muscular-atrophy-drug-study-120911/ 2011-09-11T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/efcg-endorses-new-generic-drug-user-fees-act-by-fda-120911/ 2011-09-12T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-complete-response-letter-to-janssen-biotech-arthritis-drug-sbla-120911/ 2011-09-12T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/silence-therapeutics-interna-collaborate-to-develop-cancer-therapeutics-120911/ 2011-09-12T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/ark-psioxus-sign-manufacturing-agreement-120911/ 2011-09-12T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-provides-definitive-guidance-to-develop-epicept-ceplene-120911/ 2011-09-12T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/diamyd-receives-fund-to-develop-nerve-targeting-drug-delivery-system-120911/ 2011-09-12T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/human-antibody-company-humabs-biomed-debuts-120911/ 2011-09-12T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-to-introduce-idiopathic-pulmonary-fibrosis-drug-in-germany-120911/ 2011-09-12T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-files-bcc-drug-nda-with-fda-130911/ 2011-09-12T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-bgi-team-up-to-develop-biomarkers-genomic-technologies-130911/ 2011-09-13T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/biodata-takes-over-lablife-software-130911/ 2011-09-13T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/frontage-spaulding-strengthen-business-in-china-130911/ 2011-09-13T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/avedro-vibex-gets-fda-orphan-drug-status-130911/ 2011-09-13T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/exonhit-revenues-fall-in-six-months-results-130911/ 2011-09-13T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics-q4-revenues-down-130911/ 2011-09-13T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/hemaquest-concludes-recruitment-in-hqk-1001-phase-2-trial-130911/ 2011-09-13T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/naturex-new-jersey-industrial-site-meets-brc-global-standards-130911/ 2011-09-13T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-company-introduces-argatroban-injection-130911/ 2011-09-13T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/reneuron-updates-on-stroke-drug-in-pisces-phase-i-trial-130911/ 2011-09-13T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/french-regulatory-agency-allows-nanobiotix-to-begin-nbtxr3-phase-i-trial-130911/ 2011-09-13T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-amicus-start-patient-dosing-in-phase-iii-fabry-drug-trial-130911/ 2011-09-13T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-names-new-ceo-130911/ 2011-09-13T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/novalix-in-drug-research-pact-to-develop-trisomy-21-drug-130911/ 2011-09-13T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/human-stem-cell-institute-xenetic-partner-to-invest-in-biotech-sector-130911/ 2011-09-13T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/scm-pharma-to-open-new-formulation-development-capability-200911/ 2011-09-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-to-supply-polymedco-oncologic-test-devices-140911/ 2011-09-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-rolls-out-anti-epileptic-drug-140911/ 2011-09-13T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/pharco-pharma-deploys-veeva-crm-solution-140911/ 2011-09-13T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-to-market-neovisc-single-dose-pre-filled-syringe-in-eu-140911/ 2011-09-14T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-obt-sign-deal-to-develop-adcs-for-cancer-140911/ 2011-09-14T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmavite-to-establish-new-manufacturing-plant-in-alabama-140911/ 2011-09-14T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-achieves-second-milestone-under-morphosys-collaboration-140911/ 2011-09-14T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/acceleron-pharma-starts-phase-1-ace-536-trial-140911/ 2011-09-14T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-wagon-signs-deal-with-garden-of-life-140911/ 2011-09-14T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmasset-starts-screening-in-hcv-drug-quantum-phase-2b-trial-140911/ 2011-09-14T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/viocare-purchases-royal-dsm-personalized-nutrition-division-140911/ 2011-09-14T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-allows-trimel-to-start-compleotrt-phase-iii-trial-140911/ 2011-09-14T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-commences-phase-ii-elagolix-trial-140911/ 2011-09-14T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/acucela-otsuka-commence-opa-6566-phase-12-trial-140911/ 2011-09-14T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/quotient-clinical-in-pact-with-phico-therapeutics-140911/ 2011-09-14T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-bl-1021-shows-efficacy-in-phase-ib-trial-140911/ 2011-09-14T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-pharma-generic-anti-epileptic-drug-gets-fda-nod-150811/ 2011-09-14T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-galvus-shows-efficacy-in-type-2-diabetes-trial-150911/ 2011-09-15T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/conjuchem-starts-patient-recruitment-in-type-2-diabetes-drug-trial-150911/ 2011-09-15T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/thorne-research-to-introduce-new-bariatric-dietary-supplements-product-line-150911/ 2011-09-15T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-chooses-icentera-sales-enablement-saas-platform-150911/ 2011-09-15T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-to-fund-dbm-cfcl-drug-discovery-program-150911/ 2011-09-15T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/avila-concludes-patient-dosing-in-avl-292-phase-1b-trial-150911/ 2011-09-15T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-allows-astellas-theravance-to-market-vibativ-150911/ 2011-09-15T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/pediatrx-signs-pact-with-bi-coastal-pharma-for-aquoral-150911/ 2011-09-15T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bioniche-total-revenues-fall-in-fy-11/ 2011-09-15T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/swissmedic-accepts-eisai-epilepsy-drug-for-review-150911/ 2011-09-15T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/shangpharma-hengrui-ink-rd-pact-150911/ 2011-09-15T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-to-submit-oa-drug-snda-150911/ 2011-09-15T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ono-pharma-to-develop-kai-pharma-hyperparathyroid-drug-150911/ 2011-09-15T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/viamet-pharma-starts-dosing-in-phase-1-vt-1161-trial-150911/ 2011-09-15T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/pall-q4-net-sales-up-150911/ 2011-09-15T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/clariant-launches-mevopur-additives-for-pharmaceutical-packaging-150911/ 2011-09-15T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/nanoviricides-to-lease-portion-of-inno-haven-light-industrial-building-200911/ 2011-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-plans-to-advance-cancer-diagnostic-technologies-160911/ 2011-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-mclaren-sign-strategic-collaboration-agreement-160911/ 2011-09-16T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/qualitest-pharma-recalls-oral-contraceptives-160911/ 2011-09-16T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-rolls-out-anti-epileptic-drug-160911/ 2011-09-16T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/rite-aid-optumhealth-to-launch-nowclinic-online-care-services-160911/ 2011-09-16T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharma-to-invest-in-cdi-160911/ 2011-09-16T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/tpu-verde-sign-deal-to-develop-solutions-for-pharma-disposal-160911/ 2011-09-16T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cellerant-gets-additional-funding-from-barda/ 2011-09-16T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fidia-to-get-back-hyalgan-commercial-rights-from-sanofi-160911/ 2011-09-16T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/vbi-acquires-epixis-160911/ 2011-09-16T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-to-resubmit-qnexa-nda-160911/ 2011-09-16T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-reports-hemophilia-drug-positive-results-160911/ 2011-09-16T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/covidien-to-establish-new-rd-center-in-china-160911/ 2011-09-16T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/china-botanic-q3-net-sales-rise-336-160911/ 2011-09-16T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/evaluatepharma-expands-to-japan-160911/ 2011-09-16T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-use-roche-cardio-instrument-for-drug-discovery-process-160911/ 2011-09-16T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/destinationrx-to-rebrand-as-drx-190911/ 2011-09-18T20:08:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-prolia-shows-efficacy-in-phase-2-extension-study-190911/ 2011-09-19T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-sjia-drug-phase-iii-trial-meets-primary-secondary-endpoints-190911/ 2011-09-19T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-releases-heplisav-phase-3-study-results-190911/ 2011-09-19T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-grants-21m-to-vaxin-for-anthrax-vaccine-190911/ 2011-09-19T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-licenses-otc-nalox-drug-to-meda-190911/ 2011-09-19T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-gets-fda-acceptance-for-cranbury-manufacturing-palnt-190911/ 2011-09-19T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/selcia-neurovive-sign-rd-pact-to-develop-mitochondrial-medicines-190911/ 2011-09-19T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-merges-with-edt-190911/ 2011-09-19T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/spinifex-completes-treatment-in-phase-2-ema401-trial-190911/ 2011-09-19T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/berkshire-hathaway-acquires-lubrizol-190911/ 2011-09-19T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/vical-vaxfectin-wins-international-patents-190911/ 2011-09-19T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/pronova-starts-patient-dosing-in-phase-i-prc-4016-trial-190911/ 2011-09-19T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/inhibitex-starts-dosing-in-phase-2-hcv-drug-trial-190911/ 2011-09-19T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/kythera-receives-funding-to-conduct-atx-101phase-iii-trial-190911/ 2011-09-19T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/novadigm-reports-candida-vaccine-positive-preclinical-results-190911/ 2011-09-19T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/lincoln-gives-anapen-uk-ireland-distribution-rights-to-allergy-therapeutics/ 2011-09-19T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-amphastar-enoxaparin-sodium-injection-200911/ 2011-09-19T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-to-merge-with-azur-pharma-200911/ 2011-09-20T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/russia-funds-incuron-to-develop-curaxins-200911/ 2011-09-20T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-appoints-raymond-hill-as-ceo-200911/ 2011-09-20T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/glycotope-recruits-first-patient-in-trasgex-phase-i-trial-200911/ 2011-09-20T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/pacific-biosciences-signs-deal-with-cycle-computing-200911/ 2011-09-20T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-ships-fluzone-intradermal-in-us-200911/ 2011-09-20T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/neurocrine-starts-tardive-dyskinesia-drug-phase-ii-trial-200911/ 2011-09-20T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sk-biopharmaceuticals-mayo-to-develop-als-drugs-200911/ 2011-09-20T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/marshall-edwards-starts-dosing-in-phase-i-me-143-drug-trial-200911/ 2011-09-20T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/nuevolution-signs-agreement-with-boehringer-200911/ 2011-09-20T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/hsa-terminates-jayson-pharma-otc-fever-drug-200911/ 2011-09-20T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/btg-glucarpidase-bla-gets-fda-acceptance-for-review-200911/ 2011-09-20T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/silence-names-thomas-christely-as-new-ceo-200911/ 2011-09-20T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/toyobo-to-co-promote-catalent-gpex-technology-in-japan-220911/ 2011-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-extends-agreement-with-saladax-biomedical-210911/ 2011-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/matrix-hivaids-drug-receives-tentative-approval-from-fda-210911/ 2011-09-21T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-receives-additional-marketing-rights-for-cancer-drug-210911/ 2011-09-21T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharma-rolls-out-type-2-diabetes-drug-in-japan-210911/ 2011-09-21T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-gets-banned-substance-free-certification-for-eas-nutrition-products-210911/ 2011-09-21T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectricon-designates-david-burns-as-ceo-210911/ 2011-09-21T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-signs-rd-pact-with-uc-san-diego-for-acne-treatment-210911/ 2011-09-21T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/tibotec-hcv-drug-gets-ec-nod-210911/ 2011-09-21T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-inspiration-team-up-to-manufacture-hemophilia-b-drug-210911/ 2011-09-21T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/neurologix-names-adrian-adams-as-chairman-ceo-210911/ 2011-09-21T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sanbio-starts-phase-12a-sb623-drug-trial-210911/ 2011-09-21T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/theraclone-doses-first-patient-in-phase-1-tcn-032-drug-trial-210911/ 2011-09-21T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/repros-starts-patient-dosing-in-phase-2-low-dose-proellex-trial-210911/ 2011-09-21T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/tokai-pharma-receives-23m-funding-in-series-d3-financing-210911/ 2011-09-21T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-signs-research-agreement-with-dana-farberpartners-210911/ 2011-09-21T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/h-lundbeck-pays-research-milestone-to-vernalis-210911/ 2011-09-21T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fkd-to-develop-merck-gene-therapy-portfolio-210911/ 2011-09-21T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-roche-to-resolve-cancer-drug-patent-dispute-220911/ 2011-09-22T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/intralytix-and-pg-to-develop-phage-based-technology-220911/ 2011-09-22T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-new-patent-to-celator-pharma-220911/ 2011-09-22T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/sinclair-invida-introduce-two-sinclair-dermatology-products-220911/ 2011-09-22T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/rockefeller-university-licenses-lysin-enzyme-to-contrafect-220911/ 2011-09-22T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/novimmune-starts-poc-study-of-pbc-drug-220911/ 2011-09-22T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/md-anderson-hjf-license-cancer-vaccine-to-rxi-pharma-220911/ 2011-09-22T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/zymeworks-gets-81m-funding-to-develop-azymetric-albucore-220911/ 2011-09-22T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/trophos-treats-last-patient-in-als-phase-three-drug-trial-220911/ 2011-09-22T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/mwi-veterinary-supply-acquires-micro-220911/ 2011-09-22T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/btg-sells-acute-migraine-compound-to-ariel-pharma-220911/ 2011-09-22T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/foundation-fighting-blindness-funds-applied-genetic-220911/ 2011-09-22T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-widens-laboratory-testing-services-220911/ 2011-09-22T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/kary-mullis-loxbridge-sign-jv-to-form-altermune-220911/ 2011-09-22T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/eleven-biotherapeutics-names-abbie-celniker-as-ceo/ 2011-09-22T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/onglyza-drug-used-with-insulin-reduces-sugar-levels-in-type-2-diabetes-patients-230911/ 2011-09-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-secures-business-deal-with-chinese-company-270911/ 2011-09-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immunogen-files-nhl-drug-ind-with-fda-230911/ 2011-09-23T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/momenta-pharma-sandoz-sue-amphastar-watson/ 2011-09-23T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-rolls-out-generic-alzheimers-drug-230911/ 2011-09-23T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ambrx-bms-sign-deal-for-novel-biologics-programs-230911/ 2011-09-23T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/acetylon-pharma-starts-treating-patients-in-phase-1-2a-multiple-myeloma-drug-trial-230911/ 2011-09-23T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/skinvisible-gets-european-patent-notice-for-invisicare-230911/ 2011-09-23T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-hiv-drug-gets-ema-positive-opinion-230911/ 2011-09-23T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/soy-protein-consumption-to-minimize-progression-of-clogged-arteriesstudy-230911/ 2011-09-23T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-approves-astrazeneca-faslodex-500mg-260911/ 2011-09-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biotech-remicade-uc-drug-gets-fda-nod-260911/ 2011-09-26T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-releases-positive-results-from-bolero-2-phase-iii-trial-260911/ 2011-09-26T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-trastuzumab-emtansine-shows-efficacy-in-phase-ii-trial-260911/ 2011-09-26T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/phyaura-rolls-out-ehr-community-edition-260911/ 2011-09-26T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/4sc-hl-drug-resminostat-gets-orphan-drug-status-from-fda-260911/ 2011-09-26T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/asahi-kasei-osteoporosis-drug-gets-japanese-approval-260911/ 2011-09-26T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/japanese-mhlw-approves-chugai-pharma-avastin-260911/ 2011-09-26T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-japan-eisai-seek-additional-indication-for-humira-in-japan/ 2011-09-26T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-names-maris-hartmanis-as-ceo-260911/ 2011-09-26T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-grants-273m-to-ramp-up-neumedicines-hemamax-development-260911/ 2011-09-26T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/selvita-in-pact-with-evestra-to-deliver-dmpk-services-260911/ 2011-09-26T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-completes-patient-recruitment-in-ptcl-registration-trial-260911/ 2011-09-26T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-pah-drug-shows-efficacy-in-phase-iii-trial-260911/ 2011-09-26T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ts-pharma-to-sell-radient-pharmaceuticals-onko-sure-test-270911/ 2011-09-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/4medica-rolls-out-mobile-app-for-physicians-270911/ 2011-09-26T18:59:00+00:00 https://www.pharmaceutical-business-review.com/news/bizmatics-prognocis-users-receive-stimulus-checks-following-emr-implementation-270911/ 2011-09-26T20:55:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-pharma-introduces-generic-birth-control-pill-270911/ 2011-09-27T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-agrees-to-jointly-develop-research-technologies-with-cdrd-270911/ 2011-09-27T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mesoblast-lonza-sign-manufacturing-deal-270911/ 2011-09-27T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/biotie-to-take-over-newron-for-eur45m-270911/ 2011-09-27T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/napp-technologies-rolls-out-soft-shield-hand-sanitizer-270911/ 2011-09-27T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/enterabio-releases-osteoporosis-drug-phase-1-trial-results-270911/ 2011-09-27T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharma-introduces-paclitaxel-injection-usp-280911/ 2011-09-28T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/antioxidant-supplements-witness-soaring-demand-280711/ 2011-09-28T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/vesco-vitamins-unveils-supplement-capsules-280711/ 2011-09-28T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-japan-eisai-to-introduce-humira-prefilled-syringe-20mg04ml-in-japan-280911/ 2011-09-28T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/chinese-moa-licenses-sinovac-to-produce-rabend-280911/ 2011-09-28T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lannett-loxapine-capsules-280911/ 2011-09-28T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/agenix-submits-manufacturing-patent-application-for-hepatitis-b-drug-280911/ 2011-09-28T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-widens-licensing-deal-with-riemser-280911/ 2011-09-28T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/telstar-supplies-lyophilization-system-to-zambon-r-pharm-280911/ 2011-09-28T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-fcn-to-topas-elastomer-e-140-coc-elastomer-280911/ 2011-09-28T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/roflumilast-trial-shows-reduced-exacerbations-in-copd-patients-280911/ 2011-09-28T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biophytis-wins-grant-to-develop-sarcopenic-obesity-products-280911/ 2011-09-28T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/circassia-toleromune-hay-fever-vaccine-shows-efficacy-in-phase-ii-trial-280911/ 2011-09-28T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-files-vectura-nva237-with-ema-for-marketing-authorization-280911/ 2011-09-28T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/biopartners-lgls-reports-human-growth-hormone-trial-results-280911/ 2011-09-28T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/photocure-ipsen-sign-hexvix-commercialization-pact-280911/ 2011-09-28T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/gavi-alliance-to-launch-rotavirus-pneumococcal-vaccines/ 2011-09-28T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/transcept-pharma-refiles-intermezzo-nda-280911/ 2011-09-28T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/frutarom-gets-new-patent-for-fenulife-280911/ 2011-09-28T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/theracrine-names-steven-kelly-as-ceo-280911/ 2011-09-28T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/sca-takes-over-micronics-290911/ 2011-09-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioniche-to-introduce-new-products-in-australia-north-america-290911/ 2011-09-29T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/jj-acquires-interest-in-jj-merck-jv-290711/ 2011-09-29T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-starts-phase-12-hti-501-trial-290911/ 2011-09-29T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/chelsea-files-northera-nda-with-fda-290911/ 2011-09-29T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-to-take-over-graceway-us-canadian-assets-290911/ 2011-09-29T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-awards-contracts-for-development-of-ars-drugs-290711/ 2011-09-29T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-completes-patient-enrollment-in-cancer-drug-trial-290711/ 2011-09-29T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/synageva-expands-clinical-trial-in-infants-with-lal-deficiency-290711/ 2011-09-29T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ym-biosciences-recruits-first-patients-in-phase-ii-bid-trial-290911/ 2011-09-29T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/hypha-joins-ferrer-grupo-for-drug-discovery-290711/ 2011-09-29T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-valeant-pharma-colesevelam-290911/ 2011-09-29T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/onyx-pharma-files-carfilzomib-nda-290911/ 2011-09-29T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/galenea-receives-two-sbir-grants-to-develop-treatments-for-schizophrenia-290911/ 2011-09-29T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-pharma-gets-noa-for-two-patent-applications-on-zertane-in-canada/ 2011-09-29T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-to-cease-darexaban-maleate-development-290911/ 2011-09-29T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/eurostars-funds-neurovive-to-bbb-to-develop-stroke-therapy-290911/ 2011-09-29T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-proximagen-sign-deal-290911/ 2011-09-29T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bibf-1120-shows-positive-results-for-metastatic-colorectal-cancer-290711/ 2011-09-29T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-submits-nda-for-rheumatoid-arthritis-drug-290711/ 2011-09-29T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/aptiv-solutions-receives-breast-cancer-vaccine-trial-290711/ 2011-09-29T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/allon-receives-us-patent-for-preclinical-compound-290711/ 2011-09-29T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/cog-apeiron-to-conduct-apn301-trial-in-neuroblastoma-patients-290911/ 2011-09-29T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-care-communications-offer-icd-10-solution-to-healthcare-industry-300911/ 2011-09-29T23:01:00+00:00 https://www.pharmaceutical-business-review.com/news/invitria-expands-cell-culture-supplements-distribution-300911/ 2011-09-30T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/durata-begins-patient-enrollment-to-study-dalbavancin-300911/ 2011-09-30T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/sinclair-invida-launch-sinclair-dermatology-prodcuts-in-asia-pacific-300911/ 2011-09-30T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/phytopharm-cogane-receives-orphan-drug-status-by-ec-300911/ 2011-09-30T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-university-develops-technology-to-predict-anti-cancer-products-300911/ 2011-09-30T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-files-patent-infringement-litigation-with-handa-300911/ 2011-09-30T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-submits-maa-for-linaclotide-300911/ 2011-09-30T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-funds-development-of-oral-radiation-drug-300911/ 2011-09-30T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/geron-appoints-john-a-scarlett-as-new-ceo-300911/ 2011-09-30T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/array-biopharma-announces-results-of-selumetinib-trial-300911/ 2011-09-30T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/allied-healthcare-secures-486m-equity-funding-for-vaccine-development-300911/ 2011-09-30T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/trius-beguns-absssi-phase-3-trial-300911/ 2011-09-30T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-rivaroxaban-trial-meets-end-point-300911/ 2011-09-30T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-collaborates-with-proximagen-300911/ 2011-09-30T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/niaid-awards-sbir-grant-to-g-zero-300911/ 2011-09-30T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/limestone-tristar-in-new-diagnovus-company-collaboration-031011/ 2011-10-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/iba-introduces-proton-therapy-solutions-for-cancer-031011/ 2011-10-02T19:55:00+00:00 https://www.pharmaceutical-business-review.com/news/tianyin-completes-environmental-assessment-at-jcm-031011/ 2011-10-03T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/polyclinic-launches-hdl-research-031011/ 2011-10-03T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/coventry-partners-retail-pharmacy-stores-to-introduce-prescription-drug-plan-031011/ 2011-10-03T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/biotron-begins-hiv-drug-trial-031011/ 2011-10-03T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/breast-cancer-tumors-decrease-on-blueberry-consumption-bri-study-031011/ 2011-10-03T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/intellect-neurosciences-viropharma-enter-ox1-licensing-agreement-031011/ 2011-10-03T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sagent-clindamycin-injection-031011/ 2011-10-03T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-establishes-new-manufacturing-facility-in-new-jersey-031011/ 2011-10-03T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/vegenics-files-cancer-drug-ind-to-fda-031011/ 2011-10-03T08:28:00+00:00 https://www.pharmaceutical-business-review.com/news/clinicalrm-receives-medical-research-contract-by-nmrc-031011/ 2011-10-03T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-maa-by-inspiration-for-hemophilia-drug-031011/ 2011-10-03T09:00:00+00:00 https://www.pharmaceutical-business-review.com/news/stopain-debuts-in-canada-031011/ 2011-10-03T09:16:00+00:00 https://www.pharmaceutical-business-review.com/news/niper-inks-mou-with-russia-over-pharmaceutical-research-031011/ 2011-10-03T09:23:00+00:00 https://www.pharmaceutical-business-review.com/news/servier-galapagos-to-develop-cancer-treatments-031011/ 2011-10-03T09:35:00+00:00 https://www.pharmaceutical-business-review.com/news/exco-intouch-receives-3m-from-sep-041011/ 2011-10-03T20:52:00+00:00 https://www.pharmaceutical-business-review.com/news/icon-joins-oracle-for-clinical-data-management-041011/ 2011-10-03T21:07:00+00:00 https://www.pharmaceutical-business-review.com/news/santaris-to-present-miravirsen-drug-efficacy-results-041011/ 2011-10-04T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-company-introduces-new-cleviprex-formulation-041011/ 2011-10-04T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-company-teva-settle-angiomax-patent-litigations-041011/ 2011-10-04T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-introduces-benefix-in-europe-041011/ 2011-10-04T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-receives-biothrax-supply-award-041011/ 2011-10-04T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/us-to-phase-out-otc-asthma-inhalers-citing-environmental-concerns-041011/ 2011-10-04T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/somaxon-receives-fda-feedback-on-silenor-otc-regulatory-pathway-041011/ 2011-10-04T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/mission-pharmacal-trilogic-to-develop-drug-delivery-system-041011/ 2011-10-04T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/esr-secures-5-year-influenza-virus-research-contract-041011/ 2011-10-04T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/oxea-increases-manufacturing-capacity-041011/ 2011-10-04T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pct-inks-vaccine-manufacturing-agreement-with-imuc-041011/ 2011-10-04T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/dong-a-to-set-up-biosimilar-production-plant-in-songdo-041011/ 2011-10-04T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-servier-attains-research-milestone-041011/ 2011-10-04T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/mymetics-regains-intra-nasal-influenza-vaccine-from-solvay-041011/ 2011-10-04T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-antares-vibex-technology-071011/ 2011-10-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-to-expand-coagulation-testing-product-line-in-north-america-051011/ 2011-10-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/voicetech-introduces-patient-communication-services-for-pharmacies-051011/ 2011-10-04T21:11:00+00:00 https://www.pharmaceutical-business-review.com/news/vha-unveils-new-database-solution-for-healthcare-organizations-051011/ 2011-10-05T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/neuralstem-earns-patent-allowance-for-neuronal-growth-compounds-051011/ 2011-10-05T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/ventana-secures-fda-approval-for-h-pylori-antibody-051011/ 2011-10-05T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/cdrd-todai-ink-joint-research-agreement-051011/ 2011-10-05T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/datatrak-specialty-biotech-enter-multi-year-deal-051011/ 2011-10-05T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/phytopharm-receives-grant-to-develop-glaucoma-treating-drug-051011/ 2011-10-05T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cariprazine-drug-trial-shows-positive-data-051011/ 2011-10-05T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-ucb-enter-drug-discovery-collaboration-051011/ 2011-10-05T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-submits-european-registration-dossier-for-sitavir-051011/ 2011-10-05T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/prisym-to-supply-codonics-safe-label-system-051011/ 2011-10-05T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-reports-gout-drug-positive-phase-2b-trial-results-051011/ 2011-10-05T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-35m-to-nipte-to-improve-drug-manufacturing-process-051011/ 2011-10-05T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/tranzyme-begins-tzp-102-trial-in-diabetic-patients-051011/ 2011-10-05T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ridaforolimus-receives-fda-approval-as-nda-filing-051011/ 2011-10-05T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ultragenyx-ux001-receives-orphan-drug-designation-051011/ 2011-10-05T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cco-adds-new-database-to-inpractice-061011/ 2011-10-05T19:13:00+00:00 https://www.pharmaceutical-business-review.com/news/accudial-buys-stephen-key-design-071011/ 2011-10-05T20:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sinclair-adopts-crm-software-solution-061011/ 2011-10-05T21:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cdri-nitd-to-develop-tuberculosis-treatment-061011/ 2011-10-06T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biocancell-to-begin-pancreatic-cancer-clinical-trial-061011/ 2011-10-06T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-unveils-new-grf-peptide-061011/ 2011-10-06T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/teriflunomide-shows-positive-data-in-ms-treatment-061011/ 2011-10-06T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-extends-collaboaration-deal-with-celgene-on-cancer-metabolism-061011/ 2011-10-06T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/dreambrands-unveils-testosterone-boosting-supplement-061011/ 2011-10-06T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/sri-secures-143m-service-contracts-from-nci-061011/ 2011-10-06T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pivotal-selects-phoenix-healthcare-as-contract-sales-force-partner-061011/ 2011-10-06T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/puma-to-develop-pfizer-investigational-cancer-drug-061011/ 2011-10-06T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordic-nci-to-develop-vaccine-product-candidates-for-cancer-061011/ 2011-10-06T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-wins-rights-to-develop-boehringer-hiv-drug-061011/ 2011-10-06T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-unveils-tracegold-gc-column-with-safeguard-071011/ 2011-10-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sealed-air-launches-vision-safety-solutions-071011/ 2011-10-06T22:52:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-heplisav-shows-superiority-over-engerix-b-in-diabetics-071011/ 2011-10-07T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-grants-msdc-11m-to-study-msdc-0602-in-fld-tretament-071011/ 2011-10-07T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/coda-receives-6m-credit-facility-from-square-1-071011/ 2011-10-07T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-brand-of-products-to-launch-in-october-071011/ 2011-10-07T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/gerresheimer-reports-99-rise-in-third-quarter-revenues-071011/ 2011-10-07T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-introduces-generic-inhaler-071011/ 2011-10-07T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-apporves-cialis-to-treat-erectile-dysfunction-071011/ 2011-10-07T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-abraxane-for-pancreatic-cancer-treatment-shows-positive-results-071011/ 2011-10-07T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-withdraw-snda-for-lymphoma-drug-071011/ 2011-10-07T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/tgrd-discontinues-insomnia-drug-development-071011/ 2011-10-07T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/lightlake-to-conduct-phase-ii-trials-on-bulimia-nervosa-071011/ 2011-10-07T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-begins-clinical-trial-on-cat-1004-drug-candidte-071011/ 2011-10-07T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/quality-chemicals-to-develop-tenofovir-071011/ 2011-10-07T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/akorn-to-acquire-units-of-kilitch-drugs-071011/ 2011-10-07T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-emulsion-foam-anda-wins-fda-tentative-approval-071011/ 2011-10-07T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-to-discuss-adherex-thiosulfate-injection-development-071011/ 2011-10-07T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fahrenheit-nutrition-launches-new-multi-vitamin-formulas-071011/ 2011-10-07T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/grupo-ferrer-to-market-alexza-adasuve-071011/ 2011-10-07T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/decode-illumina-unveil-risk-of-gout-serum-uric-acid-levels-affecting-variants-101011/ 2011-10-10T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-amphastar-receive-tro-on-enoxaparin-101011/ 2011-10-10T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/combivent-respimat-for-copd-receives-fda-approval-101011/ 2011-10-10T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/icf-wins-contract-from-centers-for-disease-control-and-prevention-101011/ 2011-10-10T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-juvisync-for-type-2-diabetes-receives-fda-approval-101011/ 2011-10-10T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ftc-accepts-teva-acquisition-by-cephalon-101011/ 2011-10-10T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/intellipharmaceutics-posts-11m-net-income-for-third-quarter-101011/ 2011-10-10T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-introduces-olanzapine-line-101011/ 2011-10-10T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-labs-acquires-labopharm-101011/ 2011-10-10T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/starpharma-bv-treatment-phase-3-trial-receives-fda-approval-101011/ 2011-10-10T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/exiqon-introduces-products-for-rna-targeted-medicine-101011/ 2011-10-10T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bit225-trial-in-hcv-patients-yields-positive-results-101011/ 2011-10-10T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-introduces-insulin-pens-in-the-uk-101011/ 2011-10-10T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/oxis-patented-anti-oxidant-wins-gras-status-101011/ 2011-10-10T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/oxycodone-by-indian-firm-receives-tentative-fda-approval-101011/ 2011-10-10T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-infant-formula-in-israel-101011/ 2011-10-10T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/plus-diagnostics-to-open-new-diagnostic-laboratory-in-texas-111011/ 2011-10-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/accelrys-adds-heos-by-scynexis-for-drug-discovery-management-111011/ 2011-10-10T20:21:00+00:00 https://www.pharmaceutical-business-review.com/news/united-therapeutics-unit-secures-antiviral-drug-development-contract-from-nih-111011/ 2011-10-11T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-introduces-victoza-in-china-for-type-2-diabetes-111011/ 2011-10-11T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-to-present-study-on-drug-candidate-ampion-111011/ 2011-10-11T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-vgx-to-develop-vaccines-for-hepatitis-b-and-hepatitis-c-111011/ 2011-10-11T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/daval-aimspro-as-monotherapy-in-scleroderma-yields-positive-results-111011/ 2011-10-11T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/banner-submits-anda-for-targretin-111011/ 2011-10-11T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/agennix-reports-cancer-drug-phase-ii-results-111011/ 2011-10-11T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-launches-gralise-tablets-for-phn-111011/ 2011-10-11T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/anteco-pharma-to-expand-manufacturing-facility-111011/ 2011-10-11T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/njh-secures-127m-grant-to-develop-aeol-10150-111011/ 2011-10-11T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-biosciences-krn5500-shows-positive-data-in-cancer-treatment-111011/ 2011-10-11T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/aduro-treats-first-patient-in-pancreas-cancer-vaccines-phase-2-trial-111011/ 2011-10-11T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/shaanxi-aoxing-to-takeover-shaanxi-weinan-111011/ 2011-10-11T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-receives-noa-for-ctp-modified-interferons-111011/ 2011-10-11T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/exonhit-pfizer-ink-research-agreement-for-ad-biomarkers-identification-111011/ 2011-10-11T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-introduces-sartobind-pico-with-008-ml-111011/ 2011-10-11T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/stallergenes-adopts-veeva-crm-121011/ 2011-10-11T20:27:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-commences-clinical-trial-for-paz320-in-diabetics-121011/ 2011-10-12T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/copaxone-shows-positive-results-in-rrms-treatment-121011/ 2011-10-12T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zurex-pharmagra-launches-antimicrobial-formulation-121011/ 2011-10-12T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/cyanotech-expands-production-capacity-of-astaxanthin-121011/ 2011-10-12T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/incivek-debuts-in-canada-121011/ 2011-10-12T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fugeia-brana-vita-wins-eu-novel-food-approval-121011/ 2011-10-12T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-announces-positive-safety-data-review-for-libigel-121011/ 2011-10-12T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-edgemont-60-mg-depression-drug-nda-121011/ 2011-10-12T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-funds-ucsf-to-discover-antimalarial-drugs-121011/ 2011-10-12T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-invests-200m-to-set-up-manufacturing-facility-in-china-121011/ 2011-10-12T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/azelon-receives-45m-to-support-nasal-spray-development-121011/ 2011-10-12T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/celesio-acquires-stake-in-brazilian-pharma-firm-121011/ 2011-10-12T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-begins-celsentri-selzentry-trial-in-naive-hiv-patients-121011/ 2011-10-12T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-begins-patient-enrollment-for-mm-121-trial-in-her2-negative-breast-cancer-patients-121011/ 2011-10-12T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-grants-nccn-4m-to-develop-melanoma-treatment-121011/ 2011-10-12T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/glycomimetics-enters-licensing-agreement-with-pfizer-for-gmi-1070-121011/ 2011-10-12T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/oregon-selects-ramsell-mtm-solution-131011/ 2011-10-13T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/decode-pfizer-enter-research-collaboration-to-study-sle-variants-131011/ 2011-10-13T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-biopharma-submits-clinical-hold-response-for-alpha-2b-trial-131011/ 2011-10-13T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-secures-us-patent-for-anti-cancer-drug-131011/ 2011-10-13T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/mjff-grants-affiris-15m-to-study-pd-vaccine-121011/ 2011-10-13T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/agenix-inks-drug-development-deals-in-china-131011/ 2011-10-13T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/idri-receives-grant-to-develop-tb-vaccine-131011/ 2011-10-13T03:31:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-receives-resin-supply-order-from-octapharma-131011/ 2011-10-13T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/dermsafe-hand-sanitizing-lotion-receives-drp-seal-of-approval-131011/ 2011-10-13T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/sembiosys-strikes-product-development-collaboration-deal-with-tasly-pharma-131011/ 2011-10-13T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/cialis-demonstrates-positive-results-in-ed-bph-treatment-131011/ 2011-10-13T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-extends-collaboration-deal-with-chiesi-131011/ 2011-10-13T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-onyx-restructure-partnership-to-develop-cancer-treatment-131011/ 2011-10-13T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ista-pharma-reports-positive-prolensa-phase-3-trial-results-131011/ 2011-10-13T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/shield-therapeutics-commences-aegis-1-and-aegis-2-trials-of-st10-131011/ 2011-10-13T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/pozen-reports-safety-study-results-of-pa32540-131011/ 2011-10-13T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/niaid-contracts-enanta-to-develop-bicyclolide-antibiotic-131011/ 2011-10-13T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/radiant-sage-introduces-new-saas-solution-141011/ 2011-10-13T22:34:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-isentress-shows-positive-results-in-hiv-1-treatment-141011/ 2011-10-14T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-serada-for-menopausal-hot-flashes-shows-positive-data-141011/ 2011-10-14T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/derma-sciences-unveils-medihoney-gel-141011/ 2011-10-14T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/american-cryostem-opens-tissue-processing-laboratory-141011/ 2011-10-14T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/tibotec-pharmaceuticals-to-present-hiv-trial-data-at-eacs-141011/ 2011-10-14T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/galenica-submits-injectafer-nda-to-us-fda-141011/ 2011-10-14T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/coti-2-for-cancer-treatment-secures-us-patent-141011/ 2011-10-14T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-joins-russian-firm-to-manufacture-drugs-141011/ 2011-10-14T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/litha-inks-deal-with-indian-firm-to-manufacture-drugs-141011/ 2011-10-14T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-completes-product-analysis-production-run-141011/ 2011-10-14T06:09:00+00:00